Результаты поиска - Djordje Atanackovic

Elotuzumab as a novel anti-myeloma immunotherapy по Sabarinath Venniyil Radhakrishnan, Neelam Bhardwaj, Mary Steinbach, Janet Weidner, Tim Luetkens, Djordje Atanackovic

Connect to this object online.

5-Azacytidine Promotes an Inhibitory T-Cell Phenotype and Impairs Immune Mediated Antileukemic Activity по Thomas Stübig, Anita Badbaran, Tim Luetkens, York Hildebrandt, Djordje Atanackovic, Thomas M. C. Binder, Boris Fehse, Nicolaus Kröger

Connect to this object online.

Chimeric antigen receptor (CAR) T cells for the treatment of a kidney transplant patient with post-transplant lymphoproliferative disorder (PTLD) по Kathryn Kline, Wengen Chen, Michael E. Kallen, Rima Koka, Destiny Omili, Xiaoxuan Fan, Thierry Iraguha, Etse Gebru, Nishanthini Dishanthan, Jillian M. Baker, Kenneth A. Dietze, Jean A. Yared, Kim Hankey, Saurabh Dahiya, Silke V. Niederhaus, Kieron Dunleavy, Nancy M. Hardy, Tim Luetkens, Aaron P. Rapoport, Djordje Atanackovic

Connect to this object online.